je.st
news
Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer
2016-01-23 03:23:46| Biotech - Topix.net
's stock had its "outperform" rating restated by equities research analysts at Oppenheimer in a research report issued to clients and investors on Friday, MarketBeat reports. They currently have a $4.00 price objective on the biotechnology company's stock.
Tags: rating
receives
gale
outperform
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||